The IPO Buzz: CG Oncology (CGON) Scores a NASDAQ Moonshot

CG Oncology (CGON) – the first biotech IPO of the year – scored a moonshot today in its NASDAQ debut. The bladder cancer biotech doubled its $19.00 IPO price – rising to $38.00 shortly after 3 p.m. EST today (Thursday, Jan. 25, 2024). A moonshot occurs when a company doubles its IPO stock price – […]

January 25, 2024 Read More

The IPO Buzz: Amer Sports (AS) Sets Terms & Launches $1.7 Billion IPO

Whoosh! Faster than the serve of your favorite tennis star, Wilson Sporting Goods parent Amer Sports (AS proposed) set terms and launched its $1.7 billion IPO – just as the sun rose over Wall Street today (Monday, Jan. 22, 2024). Amer Sports is offering 100.0 million shares at a price range of $16.00 to $18.00. If the IPO […]

January 22, 2024 Read More

The IPO Buzz: CG Oncology Sets Terms & Launches $200.6 Million IPO

Bladder cancer biotech CG Oncology (CGON Proposed) unveiled the terms and launched its $200.6 million IPO shortly before sunrise on Wall Street today – Thursday, Jan. 18, 2024. CG Oncology is offering 11.8 million shares at $16.00 to $18.00 to raise $200.6 million. The California biotech plans to price its IPO next week – on […]

Read More
Page 22 of 56« First...10...2021222324...304050...Last »